These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8858268)

  • 1. Adaptive changes in the acute haemodynamic effects of cilazapril during chronic treatment. Comparison with long-term clinical effect.
    Larsen J; Sykulski R; Jensen G; Dössegger L; Trimarco B; Moccetti T; Glogar D; Schelling A; Bosma AH
    Eur J Clin Pharmacol; 1996; 50(6):433-41. PubMed ID: 8858268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
    Cardiology; 1995; 86 Suppl 1():34-40. PubMed ID: 7614505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.
    Bulpitt CJ; Fletcher AE; Dössegger L; Neiss A; Nielsen T; Viergutz S
    Heart; 1998 Jun; 79(6):593-8. PubMed ID: 10078088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilazapril in congestive heart failure. A pilot study.
    Kiowski W; Drexler H; Meinertz T; Zuber M; Ritz R; Burkart F; Just H
    Drugs; 1991; 41 Suppl 1():54-61. PubMed ID: 1712273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial.
    Dössegger L; Aldor E; Baird MG; Braun S; Cleland JG; Donaldson R; Jansen LJ; Joy MD; Marin-Neto JA; Nogueira E
    Eur Heart J; 1993 Jul; 14 Suppl C():18-23. PubMed ID: 8365423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of handgrip stress test on hemodynamic parameters before and after cilazapril treatment in patients with heart failure.
    Tavli T; Göçer H
    Anadolu Kardiyol Derg; 2003 Mar; 3(1):38-42. PubMed ID: 12626309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure therapy with cilazapril: an overview.
    Dössegger L; Nielsen T; Preston C; Arabatzis N
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S38-41. PubMed ID: 7700063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of felodipine and cilazapril on exercise performance in patients with mild to moderate hypertension. A crossover study.
    Paterna S; Di Pasquale P; Parrinello G; Tuttolomondo A; Follone G; Cardinale A; Ortoleva A; Giambanco F; Abruzzese G; Colomba D; Bologna P; Fernández P; Giubilato A; Valdes L; Albano V; Licata G
    Drugs Exp Clin Res; 2000; 26(4):125-31. PubMed ID: 11109512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
    Fujiwara M; Asakuma S; Nakamura T; Nakamura K; Iwasaki T
    J Cardiol; 1995 Nov; 26(5):287-92. PubMed ID: 8523261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cilazapril on exercise tolerance in congestive heart failure.
    Corder CN; Rubler S; Deere LF; Puls A; Peguero-Rivera A; Nagarajan R; Harwood W
    Pharmacology; 1993; 46(3):148-54. PubMed ID: 8441761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
    Faxon DP
    J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
    Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW
    Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide.
    Krum H; Jackson B; Conway EL; Howes LG; Johnston CI; Louis WJ
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):451-7. PubMed ID: 1279292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
    Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
    Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perindopril and chronic heart failure].
    Bounhoure JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S; Heinz G; Kleinbloesem C; Korn A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients.
    Güntzel P; Kobrin I; Pasquier C; Zimlichman R; Viskoper JR
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):8-12. PubMed ID: 1708060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.